BioMarin Pharmaceutical EBIT Margin 2010-2024 | BMRN
- BioMarin Pharmaceutical average ebit margin for 2023 was 5.05%, a 17.99% increase from 2022.
- BioMarin Pharmaceutical average ebit margin for 2022 was 4.28%, a 192.24% increase from 2021.
- BioMarin Pharmaceutical average ebit margin for 2021 was -4.64%, a 559.41% decline from 2020.
Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues